Sign In to Follow Application
View All Documents & Correspondence

Process For Manufacture Of Personal Care Products Utilizing A Concentrate Water Phase

Abstract: A process which may be continuous is provided for manufacture of personal care product compositions. The process involves feeding a first water phase which is a concentrate containing most if not all water soluble ingredients of the composition into a blending tube. A second phase which can be oily or aqueous and a third water phase, the latter being essentially pure water, are also fed into the blending tube. All of the phases are transported through the tube at a flow rate of 5 to 5,000 lbs./minute and at a pressure of 10 to 5,000 psi. Preferably the tube leads into a homogenizer such as a sonolator.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
02 June 2005
Publication Number
36/2005
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2007-08-14
Renewal Date

Applicants

HINDUSTAN UNILEVER LIMITED
Hindustan Lever House, 165/166 Backbay Reclamation, Maharashtra, 400 020 Mumbai Maharashtra India

Inventors

1. DIVONE, PETER, ANTHONY
Unilever Home & Personal Care USA, 40 Merritt Boulevard, Trumbull, CT 06611
2. BIERCEVICZ WALTER ANTHONY
9 WAGON WHEEL DRIVE PROSPECT CONNECTICUT 06712
3. REGAN JOSEPH JAMES
UNILEVER HOME & PERSONAL CARE USA 40 MERRITT BOULEVARD TRUMBULL CONNECTICUT 06611
4. PRIST KIMBERLY ANN
68 MYRA ROAD HAMDEN CONNECTICUT 06517
5. BRIDGES CHRISTY ANN
5 ANGELE'S WAY GOSHEN NEW YORK 10924
6. JUNGBLUT MATTHEW PETER
UNILEVER HOME & PERSONAL CARE USA 3100 GOLF ROAD ROLLING MEADOWS CHICAGO ILLINOIS 60008

Specification

J6783
FORM - 2
THE PATENTS ACT, 1970
(39 of 1970)
&
The Patents Rules, 2003
COMPLETE SPECIFICATION
(See Section 10 and Rule 13)
PROCESS FOR MANUFACTURE OF
PERSONAL CARE PRODUCTS UTILIZING A
CONCENTRATE WATER PHASE
HINDUSTAN LEVER LIMITED, a company incorporated under the Indian Companies Act, 1913 and having its registered office at Hindustan Lever House, 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India
The following specification particularly describes the invention and the manner in which it is to be performed.

WO 2004/054695

PCT/EP2003/012419

PROCESS FOR MANUFACTURE OF PERSONAL CARE PRODUCTS UTILIZING A CONCENTRATE WATER PHASE
The invention concerns a process for manufacture of liquid 5 personal care products which minimizes, equipment requirements increases capacity and reduces manufacturing times.
Among the most widely used personal care products of the liquid type are shampoos, shower gels and skin lotions. Ordinarily each of these products are marketed in a variety 10 of colors with different fragrances and promotional
ingredients. More efficient ways are continuously being sought for their manufacture.
Particularly sought are systems which can minimize equipment, increase capacity and reduce formulation time.
15 In a first aspect, the invention provides a process for manufacture of personal care compositions which includes:
(i) feeding a first water phase having a viscosity from about 50 to about 30,000 cps into a blending tube;
(ii) feeding a second phase into the blending tube;
20 (iii) feeding a third phase having a viscosity of less than 3 0 cps into the blending tube, the third phase being at least about 15 % of the composition;
(iv) mixing together all three of the phases, each of
25 the phases being pumped into the blending tube as

WO 2004/054695

PCTVEP2003/012419

- 2 -
a liquid stream at a pressure from about 10 to about 5,000 psi and at a flow rate of about 2.27 to 2,270 kg (5 to about 5,000 pounds) per minute; and
5 (v) recovering a resultant mixture as a personal care composition.
Advantages and features of the present invention will become more readily apparent from consideration of the drawings, in which:
10 Fig. 1 is a schematic of a first embodiment according to the present process; and
Fig. 2 is a schematic of a second embodiment according to the present process.
Now it has been found that significant manufacturing 15 efficiencies can be achieved for the production of personal care compositions. The advance is based upon a first water phase concentrate incorporating most of any water soluble ingredients found in the final personal care composition. The concentrate is then blended with a second phase. Where 20 the eventual personal care composition is an emulsion such as a skin cream, the second phase will be an oil phase. Other products such as shampoos which do not contain an oil phase will be manufactured with a second phase that is aqueous and formulated with one or more surfactants. A 25 third phase provides additional water. Normally the third

WO 2004/054695

PCT/EP2003/012419

- 3 - ■
phase will be purely water, but sometimes it may carry a minor amount of further ingredients.
All three phases are blended in a tube. For the purposes of this invention, the term "blending tube" may include any 5 chamber, vessel and piping wherein all three phases come together for mixing. Ordinarily the volume of the blending tube will be relatively small. The volume may range from
about 0.0016387 to 1638.7 cm (0.0001 to about 100 cubic
3 inches), preferably from about 0.016387 to 327.74 cm (0.001
10 to about 20 cubic inches), more preferably from about
0.16387 to 81.94 cm (0.01 to about 5 cubic inches), and
optimally from about 1.6387 to 16.387 cm (0.1 to about 1 cubic inch).
Even though much of the water is eliminated from the first 15 water phase concentrate, most water-soluble ingredients can still be placed into solution or suspended. The benefit is found with the holding/blending tank which can be significantly downsized from the traditional non-concentrate process. Less mixing equipment is necessary and less tank 2 0 space is required. Top-off water in the form of an
additional water (third) phase reconstitutes the concentrate at the point of mixing. No holding tanks or mixers are ordinarily necessary for preparing the third (water) phase. This phase may be directly pumped into the blending tube 25 from any water source such as a well or municipal water carrier.

WO 2004/054695

PCT/EP2003/012419

- 4. -
Viscosities of the first water phase concentrate will be much higher than that of the third (water) phase. More specifically, the first water phase will have a viscosity ranging from about 50 to about 3 0,000 cps, preferably from 5 about 150 to about 20,000 cps, optimally from about 300 to about 5,000 cps as measured on a Brookfield RVT Viscometer, Spindle No. RV6 at 2 0 rpm for 1 minute at 25°C.
The third (water) phase ordinarily will have virtually no other additives. Viscosity of this phase is usually less 10 than 5'cps, preferably from about 1 to 4 cps, as measured on a Brookfield RVT Viscometer, Spindle No. RV6 at 2 0 rpm for 1. minute at 25°C.
Figure 1 is a schematic flow diagram of the process according to the present invention. A concentrated first 15 water phase 2 is formulated within a tank 4. Reconstitution of the concentrate may require anywhere from two to fifty times the amount of pure water by weight to achieve the desired composition. The first phase is delivered via a pump 6 through piping to a blending tube 8.
20 A second phase 10 is held within tank 12. Often when the intended composition is a skin care product, formulation will be an emulsion requiring a water and oil phase. In this instance, the second phase will be an oil phase. Products such as shampoos and shower gels often do not
25 require an oil phase. For these types of products, the
second phase will be aqueous and usually deliver one or more surfactants. The levels of surfactants in shampoos and shower gels generally are well above 10 %. Consequently,

WO 2004/054695

PCT/EP2003/012419

- 5 -
these types of products may utilize an aqueous second phase which can include total surfactant levels ranging from about .15 % to about 90 %, preferably from about 25 % to about 75 % by weight of the second phase.
5 Delivery of the second phase into the blending tube is
mediated by a pump 14. Typical pumps can be Triplex Cat or Progressive Cavity Pumps (ex Moyno/Seepex).
A third phase 16 normally constituted only by water, but occasionally may have a few additives, is also fed into the 10 blending tube. Transfer is facilitated by a pump 18. The latter may be a Moyno/Seepex Progressive Cavity pump, a Waukesha or Positive Displacement pump.
Subsequent to leaving blending tube 8, the combination of phases 2, 10 and 16 enter a Sonolator 2 0 which operates as
15 a homogenizer thoroughly mixing all phases together under high pressure and shear. The resultant fluid is then transmitted through a back pressure valve 22. Downstream a 3-way valve 24 leads most of the product to a storage tank or directly to a package filler 26. Normally a small amount
2 0 of product is diverted via the 3-way valve into re-work reservoir 2 8 for recycling via pump 3 0 into the stream of the first phase. Amounts of rework may range from 0 to 5 0 %, preferably from 1 % to 20 I, optimally about 5 % of total product that has exited the sonolator from the blending
25 tube.
Typically the process involves formation of a first water phase in a first reactor, wherein components are mixed and

WO 2004/054695

PCT/EP2003/012419

- 6 -
maintained at a temperature from about 10 to about 70°C, preferably from about 18 to about 58°C, optimally from about 24 to about 52°C. In most but not all instances it will be preferable to have the first water phase at a temperature at 5 least about 5°C, preferably at least about 11°C, cooler than the second phase (especially where this is oil) at point of mutual blending.
The second phase will be formed in a reactor by mixing components at a temperature ranging from about 10 to about 10 150°C, preferably from about 40 to about 165°C, optimally from about 66 to about 95°C.
The third phase can be maintained at a temperature from about 0 to about 57°C, preferably from about 5 to about 45°C, optimally from about 15 to about 38°C.
15 Viscosities of the second phase as measured with a
Brookfield RVT Viscometer, Spindle No. RV6 at 20 rpm for 1 minute at 25°C, may range from about 50 to about 200,000 cps, preferably from about 1,000 to about 100,000, optimally from about 5,000 to about 50,000 cps.
2 0 Viscosities of the final personal care products normally may range between about 1,000 and about 30,000 cps, preferably between about 5,000 and about 30,000 cps, and optimally between 10,000 and 25,000 cps using the Brookfield RVT Viscometer, Spindle No. RV6 at 20 rpm for 1 minute at 25°C.
25 Deliveries.of fluids from tanks containing the first and second phases into the blending tube 8 can be achieved

WO 2004/054695

PCT/EP2003/012419

- 7 -
through a pair of electronically controlled servo-driven rotary pumps. Careful control of flow is achieved by use of blending valves available from the Oden Corporation monitored by E&H mass flow meters. The equipment may 5 include static mixing elements and back-pressure valves.
Flow rate for the first water phase and second phase into blending tube 8 may range from about 2.27 to 2,270 kg (5 to about 5,000 lbs.) per minute. Preferably the flow rate may range from about 22.7 to 454 kg (50 to about 1,000 lbs.) per 10 minute, and optimally from about 68.10 to 363.20 kg (150 to about 800 lbs.) per minute.
The geometry of the blending tube 8 should be such that residence time of the blended first, second and third phases may range from about 0.0001 seconds to about 5 minutes, 15 preferably from about 0.001 to about 120 seconds, optimally from about 0.01 to about 10 seconds.
In systems where the second phase is an oil, the temperature of the emulsion in blending tube 8 normally should be less than the temperature of the second (oil) phase as the latter 20 leaves its reactor tank. Typical emulsion temperatures
within the blending tube 8 may range from about 10 to about 82°C, preferably from about 27 to about 65°C, optimally from about 3 5 to about 55°C.
In a preferred embodiment, oil and both water (first and 25 third) phases are pumped at relatively high pressures which may range from about 10 to about 5,000 psi, preferably from

WO 2004/054695

PCT/EP2003/012419

- 8 -
about 10 0 to about 1000 psi, and optimally from about 150 to about 2 50 psi.
In one embodiment of the present invention, oil and first water phases are transferred from their respective reactors 5 through a positive displacement feed pump such as a Waukesha PD Gear Pump. Thereafter each of the separate phases are delivered through a high pressure pump such as a triplex plunger type available from the Giant Corporation, Toledo, Ohio or from the Cat Corporation. From there, each of the 10 separate water and oil phases are fed into the blending tube
8 which in a preferred embodiment is a Sonolator® available
from the Sonic Corporation, unit of General Signal.
The Sonolator is an in-line device capable of converting
the kinetic energy of a high velocity stream of liquid into 15 a high intensity mixing action. Conversion is accomplished by pumping the liquid through an orifice against a bladelike obstacle immediately in the jet stream of the liquid. The liquid itself oscillates in a stable vortexing pattern, which in turn causes the blade-like obstacle to resonate, 2 0 resulting in a high level of cavitation, turbulence and shear. The blade or knife is brought into an ultrasonic vibration by the fluid motion which causes cavitation in the liquid.
Alternative high-pressure fed homogenizers other than the 25 sonolator are the Manton Gaulin type homogenizer available from the APV Manton Corporation and the Microfluidizer available from Microfluidics Corporation. These type high pressure homogenizers contain a valve which is pressed

WO 2004/054695

PCT/EP2003/012419

- 9 -
(hydraulically or by a spring) against a fixed valve seat. Under high pressure, fluid flows through the opening in the seat and then through a gap between the valve and seat. Although geometries of different high pressure homogenizers 5 may differ in details, and may even be roughened with sharp edges, they all are generally similar. Often the high pressure homogenizer may consist of two or more valve-seat combinations.
The weight ratios of the first water phase (concentrate) to 10 the third (water) phase will be dependent upon the type of personal care composition and particular formulation ingredients. The weight ratio may range from about 1:1 to about 1:40, preferably from about 1:1 to about 1:10, optimally from about 1:1 to about 1:6.
15 The first water phase and second phase are present in a weight ratio ranging from about 50:1 to about 1:50, preferably from about 10:1 to about 1:10.
Ordinarily the third phase will be constituted solely of water. However, in certain instances this phase may contain
20 a small amount of additives. Normally the amount of those additives will constitute no more than 10 %, preferably no more than 5 %, optimally no more than 2 % by weight of the third phase. By contrast,.the first water phase (concentrate) can generally include more than 5 %,
25 preferably more than 10 %, most preferably more than 15 %,
and optimally more than 40 % by weight of the concentrate of ingredients other than water.

WO 2004/054695

PCT/EP2003/012419

- 10 -
Fig. 2 illustrates a slightly modified process from the one described by Fig. 1. The modification involves addition of a thickener in water as a fourth phase 32 via a pump 34 into the blending tube. Ordinarily, thickeners can be formulated 5 via the first phase. However, some types of final product are required to be exceptionally viscous. For those instances, a separate phase is found to be more efficient for incorporating relatively large amounts of a thickener.
Personal care compositions according to this invention may 10 include shampoos, shower gels, liquid hand cleansers, liquid dental compositions, skin lotions and creams, hair colorants, facial cleansers, and impregnated fluids absorbed on wiping articles.
Generally the first phase and/or the second phase will 15 contain a surfactant. Useful surfactants include nonionic, anionic, cationic, amphoteric, zwitterionic and surfactant combinations thereof. Overall amount of surfactant may range from about 0.1 % to about 50 %, preferably from about 2 % to about 40 %, optimally from about 15 % to about 25 % 20 by weight of the total personal care composition.
Illustrative but not limiting examples of suitable nonionic
surfactants include C10-C20 fatty alcohol or acid hydrophobes
condensed with from 2 to 100 moles of ethylene oxide or
propylene oxide per mole of hydrophobe; C2-C10 alkyl phenols
25 condensed with from 2 to 20 moles of alkylene oxides; mono-and di- fatty acid esters of ethylene glycol such as ethylene glycol'distearate'; fatty acid monoglycerides;

WO 2004/054695

PCT/EP2003/012419

- 11 -
sorbitan mono- and di- C8-C20 fatty acids; and polyoxyeihylene sorbitan available as Polysorbate 80 and
(5)
Tween 80^ as well as combinations of any of the above surfactants.
5 Other useful nonionic surfactants include alkyl
polyglycosides (APGs), saccharide fatty amides (e.g. methyl gluconamides) as well as long chain tertiary amine oxides. Examples of the latter category are: dimethyldodecylamine oxide, oleyldi(2-hydroxyethyl) amine oxide, 10 dimethyloctylamine oxide, dimethyldecylamine oxide, dimethyltetradecylamine oxide, di(2-
hydroxyethyl)tetradecylamine oxide, 3-didodecyloxy-2-hydroxypropyldi(3-hydroxypropyl) amine oxide, and dimethylhexadecylamine oxide.
15 Illustrative but not limiting examples of anionic surfactants include the following:
(1) Alkyl benzene sulfonates in which the alkyl
group contains from 9 to 15 carbon atoms,
preferably 11 to 14 carbon atoms in straight chain
20 or branched chain configuration. Especially
preferred is a linear alkyl benzene sulfonate containing about 12 carbon atoms in the alkyl chain.
(2) Alkyl sulfates obtained by sulfating an
25 alcohol having 8 to 22 carbon atoms, preferably 12
to 16 carbon atoms. The alkyl sulfates have the

WO 2004/054695

PCT/EP2003/012419

- -12 -
formula ROSO3-M where R is the Cs-22 alkyl group and M is a mono- and/or divalent cation.
(3) Paraffin sulfonates having 8 to 22 carbon
atoms, preferably 12 to 16 carbon atoms, in the
5 alkyl moiety.
(4) Olefin sulfonates having 8 to 22 carbon
atoms, preferably 12 to 16 carbon atoms. Most
preferred is sodium C14-C16 olefin sulfonate, available as Bioterge AS 40®.
10 (5) Alkyl ether sulfates derived from an alcohol
having 8 to 22 carbon atoms, preferably 12 to 16 carbon atoms, ethoxylated with less than 30, preferably less than 12, moles of ethylene oxide. Most preferred is sodium lauryl ether sulfate
15 formed from 2 moles average ethoxylation,
commercially available as Standopol ES-2 .
(6) Alkyl glyceryl ether sulfonates having 8 to 22 carbon atoms, preferably 12 to 16 carbon atoms, in the alkyl moiety.
20 (7) Fatty acid ester sulfonates of the formula:
1 2 1
R CH(S03-M+)C02R where R is straight or branched
alkyl from about Cg to Cis, preferably C12 to Cig,
2 and R is straight or branched alkyl from about Ci

WO 2004/054695

PCT/EP2003/012419

13 -
to Cs, preferably primarily Ci, and M+ represents a mono- or divalent" cation.
(8) Secondary alcohol sulfates having 6 to 18, preferably 8 to 16 carbon atoms.
(9) Fatty acyl isethionates having from 10 to 22 carbon atoms, with sodium cocoyl isethionate being preferred.

(10) Mono- and dialkyl sulfosuccinates wherein the alkyl groups range from 3 to 20 carbon atoms each.
(11) Alkanoyl sarcosinates. corresponding to the
formula RCON(CH3) CH2CH2CO2M wherein R is alkyl or
alkenyl of about 10 to about 2 0 carbon atoms and M is a water-soluble cation such as ammonium, sodium, potassium and trialkanolammonium. Most preferred is sodium lauroyl sarcosinate.
Illustrative of cationic surfactants are C8-C22 alkyl C1-C4
di-alkyl ammonium salts such as cetyl dimethyl ammonium chloride, stearyl dimethyl ammonium methosulfate, oleyl diethylammonium phosphate, and lauryl dimethyl ammonium borate. Particularly preferred is cetrimonium chloride which is a generic term for cetyl dimethyl ammonium chloride.
Amphoteric surfactants useful for the present invention include betaines which may have the general formula

WO 2004/054695

PCT/EP2003/012419

- 14 -
RN (R )2R -COO wherein R is a hydrophobic moiety selected
from the group consisting of alkyl groups containing from 10 to 22 carbon atoms, preferably from 12 to 18 carbon atoms; alkyl aryl and aryl alkyl groups containing 10 to 22 carbon atoms with a benzene ring being treated as equivalent to about 2 carbon atoms, and similar structures interrupted by
amido or ether linkages; each R is an alkyl group
2 containing from 1 to 3 carbon atoms; and R is an alkylene
group containing from 1 to about 6 carbon atoms. Sulfobetaines such as cocoamidopropyl hydroxysultaine are also suitable.
Examples of preferred betaines are dodecyl dimethyl betaine, cetyl dimethyl betaine, dodecyl amidopropyldimethyl betaine, tetradecyldimethyl betaine, tetradecylamidopropyldimethyl betaine, and dodecyldimethylammonium hexanoate. Most preferred is cocoamidopropyl betaine available as
Tegobetaine F sold by Th. Goldschmidt AG of Germany.
Polyols are frequently present in the water phase of the present invention. Typical polyhydric alcohols include glycerol (also known as glycerin), polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, butylene glycol, 1,2,5-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. Most preferred is glycerin. Amounts of the polyols may range from about

WO 2004/054695

PCT/EP2003/012419

- 15 -
0.5 % to about 50 %, preferably between about 1 % and about 15 % by weight of the total personal care composition.
Thickeners/viscosifiers in amounts from about 0.01 % to about 10 % by weight of the total personal care composition 5 may also be included in the first water phase and/or in a separate fourth phase. As known to those skilled in the art, the precise amount of thickeners can vary depending upon the consistency and thickness of the composition which is desired. Exemplary thickeners are xanthan gum, sodium 10 carboxymethyl cellulose, hydroxyalkyl and alkyl celluloses (particularly hydroxypropyl cellulose), and cross-linked acrylic acid polymers such as those sold by B.F. Goodrich under the Carbopol trademark.
Thickeners such as modified starches and clays may also be 15 used to thicken the water phase. For instance, aluminum
starch octenyl succinate (available as DryFlo from the
National Starch and Chemical Company) is particularly
useful. Among the clays are included magnesium aluminum
(5) silicate (available as Veegum ) , hectorite clays,
20 montmorillonite clays, bentonites (e.g. Bentone® 38) and combinations thereof.
Water soluble conditioning agents may also be incorporated into the water phase. Cationic agents in monomeric and polymeric form are particularly useful for this purpose. 25 Cationic cellulose derivatives, cationic starches, copolymers of a diallyl quaternary ammonium salt and an acrylamide, quaternized vinylpyrrolidone vinylimidazole polymers,

WO 2004/054695

PCT/EP2003/012419

- 16 -
polyglycol amine condensates, quaternized collagen polypeptide, polyethylene imine, cationized silicone polymer (e.g. Amodimethicone), cationic silicone polymers providied in a mixture with other components under the trademark Dow Corning 929 (cationized emulsion), copolymers of adipic acid and dimethylaminohydroxypropyl diethylenetriamine, cationic
chitin derivatives, cationized guar gum (e.g. Jaguar C-B-S,
(ft) Gi)
Jaguar C-17, and Jaguar C-16) and quaternary ammonium salt

©
®
polymers (e.g. Mirapol^ A-15, Mirapol^ AD-1, Mirapol®, ZA-1,
10 etc., manufactured by the Miranol Division of the Rhone Poulenc Company).
Examples of the monomeric cationic conditioning agents are salts of the general structure:

15

Rl R2— N—R3
R4

X"

wherein R is selected from an alkyl group having from 12 to
22 carbon atoms, or aromatic, aryl or alkaryl groups having
2 3 4 from 12 to 22 carbon atoms; R , R , and R are independently
20 selected from hydrogen, an alkyl group having from 1 to 22 carbon atoms, or aromatic, aryl or alkaryl groups haying
from 12 to 22 carbon atoms; and X is an anion selected from
chloride, bromide, iodide, acetate, nitrate, sulfate, methyl sulfate, ethyl sulfate, tosylate, lactylate, citrate,

WO 2004/054695

PCT/EP2003/012419

- 17 -
glycolate, and mixtures thereof. Additionally, the alkyl groups can also contain either linkages or amino group substituents (e.g., the alkyl groups can contain polyethylene glycol and polypropylene glycol moieties).
5 Compositions of the present invention that are emulsions may be oil-in-water or water-in-oil, although the former is preferred. Relative weight ratios of water to oil phases of the emulsion may range from about 1,000:1 to about 1:10, preferably from about 100:1 to about 1:5, optimally from 10 about 10:1 to about 1:2 by weight of the total personal care composition.
Another component often present in the first water phase and sometimes in the other water phase(s) are preservatives. These are incorporated to protect against the growth of
15 potentially harmful microorganism. Suitable traditional preservatives are EDTA salts and alkyl ester of parahydroxybenzoic acid. Other preservatives which have more recently come into use include hydantoin derivatives, propionate salts, and a variety of quaternary ammonium
20 compounds. Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability.
Particularly preferred preservatives are iodopropynyl butyl 25 carbamate, phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, sodium dehydroacetate and benzyl alcohol. The preservatives should be selected having regard for the use of the composition and possible

WO 2004/054695

PCT/EP2003/012419

- 18 -
incompatabilities between the preservatives and other ingredients in the composition. Preservatives are typically employed in amounts ranging from 0.01 % to 2 % by weight of the total personal care composition.
5 The second phase when an oil phase will contain hydrophobic components. Most often the oil phase will incorporate an emollient which may be selected from hydrocarbons, silicones and synthetic or vegetable esters. Amounts of the emollients may range anywhere from about 0.1 % to about 30 %, preferably 10 between about 0.5 % and about 10 % by weight of the total personal care composition.
Hydrocarbons suitable for the present invention include isoparaffins, mineral oil, petrolatum and hydrocarbon waxes such as polyethylenes.
15 Silicones may be divided into the volatile and non-volatile variety. The term "volatile" as used herein refers to those materials which have a measurable vapor pressure at ambient temperature. Volatile silicone oils are preferably chosen from cyclic or linear polydimethylsiloxanes containing from
2 0 about 3 to about 9, preferably from about 4 to about 5, silicone atoms.
Non-volatile silicones useful as an emollient material include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers. The essentially non-volatile polyalkyl 25 siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from about 5 to about 100,000 centistokes at 25°C.

WO 2004/054695

PCT/EP2003/012419

- 19 -
Among suitable ester emollients are:
(1) Alkenyl or alkyl esters of fatty acids having 10 to
20 carbon atoms. Examples thereof include isopropyl;
palmitate, isononyl isononoate, oleyl myristate, oleyl
5 stearate, cetearyl stearate and oleyl oleate.
(2) Ether-esters such as fatty acid esters of ethoxylated fatty alcohols.
(3) Polyhydric alcohol esters. Ethylene glycol mono- and di-fatty acid esters, diethylene glycol mono- and di-fatty
10 acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 20 00 monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylenbe glycol monostearate, glyceryl mono- and di-
15 fatty acid esters, polyglycerol fatty esters, ethoxylated glyceryl monostearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are
20 satisfactory polyhydric alcohol esters.
(4) Wax esters such as beeswax, spermaceti, myristyl myristate, stearyl stearate.
(5) Steroid esters, of which soya sterol and cholesterol fatty acid esters are examples thereof.
25 Most preferred vegetable ester emollients are sunflower seed oil, soy sterol esters, borage seed oil, maleated soybean oil,

WO 2004/054695

PCT/EP2003/012419

- 20 -
sucrose polycottonseedate, tribehenin, sucrose polybehenate and mixtures thereof.
Fatty acids may also be included in the oil phase. These fatty acids may have from 10 to 3 0 carbon atoms. Illustrative 5 of this category are pelargonic, lauric, myristic, palmitic, stearic, isostearic, hydroxystearic, oleic, linoleic, ricinoleic, arachidic, behenic and erucic acids. AmoTints may range from 0.1 % to 25 % by weight of the total personal care composition.
10 Fragrances, colorants and promotional ingredients may also be included in the oil and either of the water phases. Colorants illustrative of the present invention include Red No. 4, Red No. 40 and the FD&C colorants Red No. 3, Red No. 6, Red No. 28, Red No. 33, Blue No. 1, Green No. 5, Yellow No. 5, all
15 the foregoing being water soluble. Oil soluble dyes may also be utilized such as Green No. 6 and D&C Violet No. 2. Active levels of these colorants may range from about 0.0001 % to about 1 %, preferably from about 0.001 % to about 0.1 % by weight of the total personal care composition.
20 The term "fragrance" is defined-as a mixture of odoriferous components, optionally mixed with a suitable solvent diluent or carrier, which is employed to impart a desired odor.
Fragrance components and mixtures thereof may be obtained from 25 natural products such as essential oils, absolutes, resinoids, resins and concretes, as well as synthetic products such as hydrocarbons, alcohols, aldehydes, ketones, ethers, carboxylic acids, esters, acetals, ketals, nitriles and the like,

WO 2004/054695

PCT/EP2003/012419

- 21 -
including saturated and unsaturated compounds, aliphatic, carbocyclic and heterocyclic compounds.
Suitable solvents, diluents or carriers for fragrance ingredients as mentioned above are for example: ethanol, 5 isopropanol, diethylene glycol monoethyl ether, dipropyl glycol and triethyl citrate.
Particularly preferred fragrance ingredients are cyclic and acyclic terpenes and terpenoids. These materials are based
10 upon isoprene repeating units. Examples include alpha and beta pinene, myrcene, geranyl alcohol and acetate, camphene, dl-limonene, alpha and beta phellandrene, tricyclene, terpinolene, allocimmane, geraniol, nerol, linanool, dihydrolinanool, citral, ionone, methyl ionone, citronellol,
15 citronellal, alpha terpineol, beta terpineol, alpha fenchol, borneol, isoborneol, camphor, terpinen-1-ol, terpin-4-ol, dihydroterpineol, methyl chavicol, anethole, 1,4 and 1,8 cineole, geranyl nitrile, isobornyl acetate, linalyl acetate, caryophyllene, alpha cedrene, guaiol, patchouli alcohol,
2 0 alpha and beta santalol and mixtures thereof.
Amounts of the fragrance may range from about 0.00001 % to about 2 %, preferably from about 0.0001 % to about 1 %, optimally from about 0.01 % to about 0.5 %, most preferably 25 from about 0.05 % to about 0.25 % by weight of the personal care composition.
Vitamins are illustrative of promotional ingredients. These include Vitamin A (retinol), Vitamin A derivatives (retinyl palmitate, retinyl linoleate, retinyl acetate and retinoic

WO 2004/054695

PCT/EP2003/012419

- 22 -
acid), Vitamin C, Vitamin C derivatives (such as ascorbyl tetraisopalmitate and magnesium ascorbyl phosphate), Vitamin E, Vitamin E derivatives (such as tocopherol acetate), biotin, niacin and DL-panthenol and combinations thereof.
5 Amounts of the promotional ingredients may range from about 0.00001 % to about 2 %, preferably from about 0.0001 % to about 1 %, optimally from about 0.001 % to about 0.5 % by weight of the total personal care composition.
The combined first and third water phases may constitute from 10 about 5 % to about 99.5 %, preferably from about 20 % to about 90 %, more preferably from about 35 % to about 8 0 %, optimally from about 45 % to about 70 % by weight of the final personal care composition.
The combined first and third water phases will contain water 15 as a major component. Usually the amount of water may range from about 30 % to about 99.9 %, preferably from about 50 % to about 95 %, more preferably from about 65 % to about 80 %, optimally from about 55 % to about 70 % by weight of the combined first and third water phases.
2 0 The term "comprising" is meant not to be limiting to any subsequently stated elements but rather to encompass non-specified elements of major or minor functional importance. In other words the listed steps, elements or options need not be exhaustive. Whenever the words "including" or "having"
25 are used, these terms are meant to be equivalent to "comprising" as defined above.

WO 2004/054695

PCT/EP2003/012419

- 23 -EXAMPLES
Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material ought to be 5 understood as modified by the word "about".
The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise illustrated.
10 Example 1
A pair of skin lotions are prepared to reflect a 2X and a 10X level of concentrate. Both concentrates with the appropriate amount of added water will attain the resultant composition 15 shown in Table I.

WO 2004/054695

PCT/EP2003/012419

TABLE I

Phase Ingredient Name Resultant
Composition
(2 Stream) 2X (3 Stream) 10X (4 Stream)
Oil Stearic Acid Glycol Stearate/
Stearamide AMP Glycerol Monostearate Cetyl Alcohol Petrolatum Mineral Oil Dimethicone 2.0217 1.1939
0.5572 0.3184
0.5
1.4
0.3 2.0217 1.1939
0.5572 0.3184
0.5
1.4
0.3 2.0217 1.1939
0.5572 0.3184
0.5
1.4
0.3
Water Water
Tetrasodium EDTA Magnesium Aluminum
Silicate Glycerin Methylparaben Titanium Dioxide
(Water Dispersible) Carbopol 934® (2%
Active in Water) Triethanolamine Aloe Vera Gel DMDM Hydantoin Fragrance 79.4078
0.1017
0.2
3.5
0.1425
0.1
9
0.7568 0.09 0.25 0.16 32.5534
0.1017
0.2
3.5
0.1425
0.1
9
0.7568 0.09 0.25 0.16 3.1699
0.1017
0.2
3.5
0.1425
0.1
0
0.7568 0.09 0.25 0.16
Water Only - 46.8544 76.2379
Carbopol® 934 Only - - 9
The oil and water phases are each separately contained in respective first and second tanks. With the aid of a progressive cavity pump (ex Moyno/Seepex), these phases are separately fed through pipes to a blending tube antechamber
section of a Sonolator®. The combined flow rate is
precisely maintained at 9.08 kg (20 lbs.)/minute at 200 psi. The water phase concentrate is held at a temperature between 24 and 52°C with capacity of the tank being 3,000 gallons.

WO 2004/054695

PCT/EP2003/012419

- 25 -
The oil phase is held at a temperature from 65 to 93°C in a 250 gallon tank.
From a third tank, the 2X concentrate experiment delivers a third stream which is pure water regulated at the same 5 pressure as that of the first water and oil phases. The pure
water phase is maintained at 15 to 38°C and pumped into the
(R)
blending tube antechamber of the Sonolator . All phases are
then homogenized together m the Sonolator^ at 500 psi.
Thereafter the combined streams are sent to a storage vessel 10 where resultant product is held at 24 to 44°C. Some of the resultant skin lotion composition is pumped by a positive displacement pump as a return stream into the blending tube of
the Sonolator . The amount of this return flow is
approximately 5 % for purposes of a new start-up or as re-work 15 product. The remainder of the composition held within the
storage vessel is sent.to a packaging line for fill into empty bottles.
The 10X concentrate employs a fourth stream of water/thickener (Carbopol 934w) . This fourth stream is pumped at similar
20 pressure and flow rate (proportioned to its proportion in the
final composition) into the blending tube antechamber of the
(R) Sonolator . All other processing is identical to that
described above for the 2X concentrate.
Example 2 25
A set of dry skin remediating lotions are prepared to reflect a 2X, 4X and 6X level of concentrates. All three concentrates

WO 2004/054695

PCT/EP2003/012419

26
with the appropriate amount of added water will attain the resultant composition shown in Table II.

WO 2004/054695 PCT/EP2003/012419
- 27 -
TABLE II

Phase Ingredient Name Resultant
Composition
(2 Stream) 2X
(3 Stream) 4X
(3 Stream) 6X
(3
Stream)
Oil Stearic Acid 2.54 2.54 2.54 2.54
Glycol
Stearate/Stearamide
AMP 1.5 1.5 1.5 1.5
Glycerol Monostearate 0.7 0.7 0.7 0.7
Cetyl Alcohol 0.4 0.4 0.4 0.4
Sunflower Seed Oil 1.25 1.25 1.25 1.25
Silicone Fluid 200 0.26 0.26 0.26 0.26
Soy Sterol 0.08 0.08 0.08 0.08
Vitamin E Acetate 0.01 0.01 0.01 0.01
Lecithin 0.04 0.04 0.04 0.04
Sodium Stearoyl Lactylate 0.1 0.1 0.1 0.1
Petrolatum 0.9375 0.9375 0.9375 0.9375
Methyl Palmitate 0.3125 0.3125 0.3125 0.3125
Water Water 81.6605 35.7205 12.7605 5.1005
Glycerin 5.5 5.5 5.5 5.5
Disodium EDTA 0.05 0.05 0.05 0.05
Mineral Blend 0.001 0.001 0.001 0.001
Magnesium Aluminum Silicate 0.2 0.2 0.2 0.2
Oat Protein 0.001 0.001 0.001 0.001
Methylparaben 0.1425 0.1425 0.1425 0.1425
Titanium Dioxide (Water Dispersible) 0.1 0.1 0.1 0.1
Carbopol 934® (2% Active) 3 3 3 3
Triethanolamine 0.813 0.813 0.813 0.813
DMDM Hydantoin 0.25 0.25 0.25 0.25
Fragrance 0.15 0.15 0.15 0.15
Vitamin A Palmitate 0.001 0.001 0.001 0.001
Keratin 0.001 0.001 0.001 0.001
Total 91.87 15.31
Water Only 45.94 68.9 76.56

WO 2004/054695

PCT/EP2003/012419

- 28 -
The oil and water phases are each separately contained in respective first and second tanks. With the aid of a progressive cavity pump (ex Moyno/Seepex), these phases are separately fed through pipes to a blending tube antechamber
5 section of a Sonolator . The combined flow rate is
precisely maintained at 22.7 kg (50 lbs.)/minute at 800 psi. The water phase concentrate is held at a temperature between 24 and 52°C with capacity of the tank being 5,000 gallons. The oil phase is held at a temperature from 65 to 93°C in a 10 250 gallon tank.
From a third tank, the 2X concentrate experiment delivers a third stream which is pure water regulated at the same pressure as that of the first water and oil phases. The pure water phase is maintained at 15 to 38°C and pumped into
15 the blending tube antechamber of the Sonolator®. All phases
are then homogenized together in the Sonolator® at 1000 psi.
Thereafter the combined streams are sent to a storage vessel where resultant product is held at 24 to 44°C. Some of the resultant dry skin lotion composition is pumped by a 2 0 positive displacement pump as a return stream into the
blending tube of the Sonolator®. The amount of this return
flow is approximately 5 % for purposes of a new start-up or as re-work product. The remainder of the composition held within the storage vessel is sent to a packaging line for 25 fill into empty bottles.
Processing for the 4X and 6X concentrates is identical to that described above for the 2X concentrate.

WO 2004/054695

PCT/EP2003/012419

Example 3
A set of shampoo formulations are prepared to reflect a 2X, 4X and 8X level of concentrates. All three concentrates 5 with the appropriate amount of added water will attain the resultant composition shown in Table III.
TABLE III

Phase Ingredient Name Resultant
Composition
(2 Stream) 2X (3 Stream) 4X (3 Stream) 8X (3 Stream)
Water Water 79.5278 38.5288 18.0278 7.7768
Fragrance 0.5000 0.5000 0.5000 0.5000
D&C RED #33 0.0002 0.0002 0.0002 0.0002
Vitamin E Acetate 0.0010 0.0010 0.0010 0.0010
Rasberry Extract 0.0010 0.0010 0.0010 0.0010
Citric Acid (50% Active) 0.0300 0.0300 0.0300 0.0300
Hydroxypropyl-methylcellulose 0.1500 0.1500 0.1500 0.1500
Tetrasodium EDTA 0.2000 0.2000 0.2000 0.2000
Glydant® 0.1000 0.1000 0.1000 0.1000
Kathon CG® 0.0400 0.0400 0.0400 0.0400
Benzophenone-4 0.0500 0.0500 0.0500 0.0500
Ammonium
Chloride 1.4000 1.4000 1.4000 1.4000
Oil 18 18 18 18
Water Only - 40.999 61.5000 71.7510
10 Processing of the shampoo is performed in a manner similar to that described under Example 2.

WO 2004/054695

PCT/EP2003/012419

- 30 -
EXAMPLE 4
A set of hair conditioners is prepared to reflect a 2X, 4X and 8X level of concentrates. All the concentrates with the appropriate amount of added water will attain the resultant composition shown in Table IV.
TABLE IV

Phase Ingredient Name Resultant
Composition
(2 Stream) 2X (3 Stream) 4X (3 Stream) 8X (3 Stream)
Water Water 73.486 32.171 11.514 1.185
Cocamidopropyl Betaine 6.028 6.028 6.028 6.028
Aloe Vera Powder 0.005 0.005 0.005 0.005
Benzophenone-4 0.100 0.100 0.100 0.100
Glycerin 1.000 1.000 1.000 1.000
PEG-10 Sunflower Seed Oil 0.100 0.100 0.100 0.100
Tetrasodium EDTA 0.051 0.051 0.051 0.051
Sodium Hydroxide
(50% Aqueous) 0.048 0.048 0.048 0.048
Ammonium Chloride 0.325 0.325 0.325 0.325
Kathon CG® 0.020 0.020 0.020 0.020
Fragrance 1.000 1.000 1.000 1.000
Color Sol. Ext Violet #2 (0.2%) 0.333 0.333 0.333 0.333
Vitamin E Acetate 0.001 0.001 0.001 0.001
Dequest2010® 0.033 0.033 0.033 0.033
Polyquaternium-10 0.100 0.100 0.100 0.100
82.630
Oil 17.37 17.37 17.37 17.37
Water Only - 41.315 61.973 72.301
All of the processing is identical to that described under Example 2 for the respective concentrates.

WO 2004/054695

PCT/EP2003/012419

31 -
CLAIMS
1. A process for manufacture of personal care compositions
comprising:
(i) feeding a first water phase having a viscosity from
5 50 to 30,000 cps into a blending tube;
(ii) feeding a second phase into the blending tube;
(iii) feeding a third phase having a viscosity of less than 3 0 cps into the blending tube, the third phase being at least 15 % of the composition;
0 (iv) mixing together all three of the phases, each of the phases being pumped into the blending tube as a liquid stream at a pressure from 10 to 5,000 psi and at a flow rate of 2.274 to 2,270 kg (5 to 5,000 pounds) per minute; and
5 (v) recovering a resultant mixture as a personal care composition.
2. The process according to claim 1 wherein the first phase
comprises more than 5 % by weight of the first phase of
ingredients other than water.
0 3. The process according to claim 1 or claim 2 wherein the first phase comprises more than 40 % by weight of the first phase of ingredients other than water.

WO 2004/054695

PCT7EP2003/012419

- 32 -
4. The process according to any one of the preceding claims wherein vthe first phase and the third phase are fed to the blending tube at a relative weight ratio of 1:1 to 1:40.
5. The process according to any one of the preceding claims wherein the first phase and the third phase are fed to the blending tube at a relative weight ratio of 1:1 to 1:10.
6. The process according to any one of the preceding claims wherein the third phase comprises no more than 10 % by weight of the third phase of ingredients other than water.
7. The process according to any one of the preceding claims wherein the third phase comprises no more than 2 %. by weight of the third phase of ingredients other than water.
8. The process according to any one of the preceding claims
wherein the blending tube has a volume ranging from
3
0.0016387 to 1638.7 cm (0.0001 to 100 cubic inches).
9. The process according to any of the preceding claims
wherein the blending tube has a volume ranging from 0.16387
to 81.94 cm (0.01 to 5 cubic inches).
10. The process according to any one of the preceding claims wherein mixing of the phases is by sonic agitation.
11. The process according to any one of the preceding claims wherein the first phase entering the tube is at least 5°C lower in temperature than that of the second phase entering the tube.

WO 2004/054695

PCT/EP2003/012419

- 33 -
12. The process according to any one of the preceding claims wherein first, second and third phases are pumped into the tube at a pressure ranging from 100 to 1,000 psi.
Dated this 2nd day o f June 2005
HINDUSTAN LEVER LIMITED
(S. Yenkatramani) Sr Patents Manager

Documents

Application Documents

# Name Date
1 208883-FORM 27-2010.pdf 2024-03-04
1 547-mumnp-2005-form-pct-isa-210(02-06-2005).pdf 2005-06-02
2 208883-FORM 27-2013.pdf 2024-03-01
2 547-mumnp-2005-form-pct-ipea-409(02-06-2005).pdf 2005-06-02
3 547-MUMNP-2005-RELEVANT DOCUMENTS [29-09-2023(online)].pdf 2023-09-29
3 547-mumnp-2005-form 3(02-06-2005).pdf 2005-06-02
4 547-MUMNP-2005-RELEVANT DOCUMENTS [20-09-2022(online)].pdf 2022-09-20
4 547-mumnp-2005-form 1(02-06-2005).pdf 2005-06-02
5 547-MUMNP-2005-RELEVANT DOCUMENTS [09-09-2021(online)].pdf 2021-09-09
5 547-mumnp-2005-power of attorney(22-07-2005).pdf 2005-07-22
6 547-mumnp-2005-form 18(13-10-2005).pdf 2005-10-13
6 547-mumnp-2005-assignment.pdf 2018-08-09
7 547-mumnp-2005-correspondence1(13-10-2005).pdf 2005-10-13
8 547-mumnp-2005-form 5(13-10-2006).pdf 2006-10-13
8 547-mumnp-2005-claims.pdf 2018-08-09
9 547-MUMNP-2005-CORRESPONDENCE(13-2-2009).pdf 2018-08-09
9 547-mumnp-2005-form 2(granted)-(13-10-2006).pdf 2006-10-13
10 547-MUMNP-2005-CORRESPONDENCE(8-2-2012).pdf 2018-08-09
11 547-mumnp-2005-correspondence-others.pdf 2018-08-09
11 547-mumnp-2005-drawind(13-10-2006).pdf 2006-10-13
12 547-mumnp-2005-claims(granted)-(13-10-2006).pdf 2006-10-13
12 547-mumnp-2005-correspondence-received-ver-131005.pdf 2018-08-09
13 547-mumnp-2005-correspondence-received-ver-131006.pdf 2018-08-09
14 547-mumnp-2005-cancelled pages(13-10-2006).pdf 2006-10-13
14 547-mumnp-2005-correspondence-received.pdf 2018-08-09
15 547-mumnp-2005-abstract(13-10-2006).pdf 2006-10-13
15 547-mumnp-2005-description (complete).pdf 2018-08-09
16 547-mumnp-2005-correspondence(ipo)-(12-03-2007).pdf 2007-03-12
16 547-mumnp-2005-drawings.pdf 2018-08-09
17 547-mumnp-2005-form-1.pdf 2018-08-09
17 547-mumnp-2005-correspondence2(09-04-2007).pdf 2007-04-09
18 547-mumnp-2005-form-18.pdf 2018-08-09
18 547-MUMNP-2005-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-(19-10-2009).pdf 2009-10-19
19 547-MUMNP-2005-CORRESPONDENCE(25-10-2011).pdf 2011-10-25
20 547-MUMNP-2005-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-(31-10-2011).pdf 2011-10-31
20 547-mumnp-2005-form-2.pdf 2018-08-09
21 547-MUMNP-2005-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-(25-10-2012).pdf 2012-10-25
21 547-mumnp-2005-form-26.pdf 2018-08-09
22 547-mumnp-2005-form-3.pdf 2018-08-09
22 abstract1.jpg 2018-08-09
23 547-mumnp-2005-form-5.pdf 2018-08-09
23 547-mumnp-2005-pct-search report.pdf 2018-08-09
24 547-mumnp-2005-form-pct-separate sheet-409.pdf 2018-08-09
24 547-mumnp-2005-form-pct-ipea-409.pdf 2018-08-09
25 547-mumnp-2005-form-pct-ipea-409.pdf 2018-08-09
25 547-mumnp-2005-form-pct-separate sheet-409.pdf 2018-08-09
26 547-mumnp-2005-form-5.pdf 2018-08-09
26 547-mumnp-2005-pct-search report.pdf 2018-08-09
27 547-mumnp-2005-form-3.pdf 2018-08-09
27 abstract1.jpg 2018-08-09
28 547-MUMNP-2005-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-(25-10-2012).pdf 2012-10-25
28 547-mumnp-2005-form-26.pdf 2018-08-09
29 547-MUMNP-2005-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-(31-10-2011).pdf 2011-10-31
29 547-mumnp-2005-form-2.pdf 2018-08-09
30 547-MUMNP-2005-CORRESPONDENCE(25-10-2011).pdf 2011-10-25
31 547-MUMNP-2005-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-(19-10-2009).pdf 2009-10-19
31 547-mumnp-2005-form-18.pdf 2018-08-09
32 547-mumnp-2005-correspondence2(09-04-2007).pdf 2007-04-09
32 547-mumnp-2005-form-1.pdf 2018-08-09
33 547-mumnp-2005-correspondence(ipo)-(12-03-2007).pdf 2007-03-12
33 547-mumnp-2005-drawings.pdf 2018-08-09
34 547-mumnp-2005-abstract(13-10-2006).pdf 2006-10-13
34 547-mumnp-2005-description (complete).pdf 2018-08-09
35 547-mumnp-2005-correspondence-received.pdf 2018-08-09
35 547-mumnp-2005-cancelled pages(13-10-2006).pdf 2006-10-13
36 547-mumnp-2005-correspondence-received-ver-131006.pdf 2018-08-09
37 547-mumnp-2005-claims(granted)-(13-10-2006).pdf 2006-10-13
37 547-mumnp-2005-correspondence-received-ver-131005.pdf 2018-08-09
38 547-mumnp-2005-correspondence-others.pdf 2018-08-09
38 547-mumnp-2005-drawind(13-10-2006).pdf 2006-10-13
39 547-MUMNP-2005-CORRESPONDENCE(8-2-2012).pdf 2018-08-09
40 547-MUMNP-2005-CORRESPONDENCE(13-2-2009).pdf 2018-08-09
40 547-mumnp-2005-form 2(granted)-(13-10-2006).pdf 2006-10-13
41 547-mumnp-2005-claims.pdf 2018-08-09
41 547-mumnp-2005-form 5(13-10-2006).pdf 2006-10-13
42 547-mumnp-2005-correspondence1(13-10-2005).pdf 2005-10-13
43 547-mumnp-2005-form 18(13-10-2005).pdf 2005-10-13
43 547-mumnp-2005-assignment.pdf 2018-08-09
44 547-MUMNP-2005-RELEVANT DOCUMENTS [09-09-2021(online)].pdf 2021-09-09
44 547-mumnp-2005-power of attorney(22-07-2005).pdf 2005-07-22
45 547-MUMNP-2005-RELEVANT DOCUMENTS [20-09-2022(online)].pdf 2022-09-20
45 547-mumnp-2005-form 1(02-06-2005).pdf 2005-06-02
46 547-MUMNP-2005-RELEVANT DOCUMENTS [29-09-2023(online)].pdf 2023-09-29
46 547-mumnp-2005-form 3(02-06-2005).pdf 2005-06-02
47 208883-FORM 27-2013.pdf 2024-03-01
47 547-mumnp-2005-form-pct-ipea-409(02-06-2005).pdf 2005-06-02
48 208883-FORM 27-2010.pdf 2024-03-04
48 547-mumnp-2005-form-pct-isa-210(02-06-2005).pdf 2005-06-02

ERegister / Renewals

3rd: 15 Oct 2007

From 03/11/2005 - To 03/11/2006

4th: 15 Oct 2007

From 03/11/2006 - To 03/11/2007

5th: 15 Oct 2007

From 03/11/2007 - To 03/11/2008

6th: 29 Oct 2008

From 03/11/2008 - To 03/11/2009

7th: 19 Oct 2009

From 03/11/2009 - To 03/11/2010

8th: 26 Oct 2010

From 03/11/2010 - To 03/11/2011

9th: 31 Oct 2011

From 03/11/2011 - To 03/11/2012

10th: 25 Oct 2012

From 03/11/2012 - To 03/11/2013

11th: 31 Oct 2013

From 03/11/2013 - To 03/11/2014

12th: 21 Oct 2014

From 03/11/2014 - To 03/11/2015

13th: 15 Oct 2015

From 03/11/2015 - To 03/11/2016

14th: 28 Oct 2016

From 03/11/2016 - To 03/11/2017

15th: 30 Oct 2017

From 03/11/2017 - To 03/11/2018

16th: 27 Oct 2018

From 03/11/2018 - To 03/11/2019

17th: 12 Oct 2019

From 03/11/2019 - To 03/11/2020

18th: 15 Sep 2020

From 03/11/2020 - To 03/11/2021

19th: 21 Oct 2021

From 03/11/2021 - To 03/11/2022